N-huMABs therapy (Immunome)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameN-huMABs therapy (Immunome)
Drug Alias Namenative human monoclonal antibodies therapy (Immunome)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNeuroprotectantsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNervous System DiseasesClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunome Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunome Inc
Active IndicationsN/A
Inactive IndicationsNervous System DiseasesClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A